logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Cannabinoids As Therapeutics 1st Edition Ethan Russo Auth

  • SKU: BELL-4388968
Cannabinoids As Therapeutics 1st Edition Ethan Russo Auth
$ 31.00 $ 45.00 (-31%)

4.1

90 reviews

Cannabinoids As Therapeutics 1st Edition Ethan Russo Auth instant download after payment.

Publisher: Birkhäuser Basel
File Extension: PDF
File size: 1.89 MB
Pages: 268
Author: Ethan Russo (auth.), Raphael Mechoulam (eds.)
ISBN: 9783764370558, 9783764373580, 3764370556, 376437358X
Language: English
Year: 2005
Edition: 1

Product desciption

Cannabinoids As Therapeutics 1st Edition Ethan Russo Auth by Ethan Russo (auth.), Raphael Mechoulam (eds.) 9783764370558, 9783764373580, 3764370556, 376437358X instant download after payment.

In recent years, cannabis research has concentrated on the potential of cannabinoids as therapeutic substances, particularly in serious chronic illnesses such as multiple sclerosis. Most volumes published on cannabinoids so far concentrate on the biological activity, biochemistry and pharmacology, whereas this volume concentrates on the diseases, the physiological effects and therapeutic use of cannabinoids. The volume editor Prof. Mechoulam was the first who isolated the prime active constituent (THC, Tetrahydrocannabiol) of marijuana. He published extensively on the pharmacological activities of cannabinoids. The volume is of interest to researchers and clinicians from pharmacology, neuroscience, and medicinal research.

Related Products